Primmune Therapeutics is developing an orally administered TLR7 agonist to stimulate innate immunity in cancer immunotherapy. Their goal is to improve the response rate of patients to current and future immunotherapy medicines.
Thermo Fisher Scientific
288 followers
Genentech
227 followers
Gilead Sciences
216 followers
Regeneron
184 followers
Biogen
167 followers
Vertex Pharmaceuticals
113 followers
Agilent Technologies
102 followers
Illumina
93 followers
Neuralink
92 followers
BioMarin Pharmaceutical
60 followers
Alexion Pharmaceuticals
58 followers
Myriad Genetics
42 followers